HHS Accused Of Overstepping Role In Drug Discount Program
The U.S. Department of Health and Human Services is wrongly barring drugmakers from requiring claims information from certain health providers when they request a ceiling price for drugs under a federal...To view the full article, register now.
Already a subscriber? Click here to view full article